Jama Network
JAMA Neurology : High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:08
- Mas informaciones
Informações:
Sinopsis
Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD. Related Content: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
